Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy

Guixiang Zhao, Ho Jeoung Nam, Shawn C. Burgess, Kimberly A. Rosaaen-Stowe, Takeshi Inagaki, Shuaib Latif, John M. Shelton, John McAnally, Rhonda Bassel-Duby, Robert Harris, James A. Richardson, Steven A. Kliewer

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

The heart adapts to changes in nutritional status and energy demands by adjusting its relative metabolism of carbohydrates and fatty acids. Loss of this metabolic flexibility such as occurs in diabetes mellitus is associated with cardiovascular disease and heart failure. To study the long-term consequences of impaired metabolic flexibility, we have generated mice that overexpress pyruvate dehydrogenase kinase (PDK)4 selectively in the heart. Hearts from PDK4 transgenic mice have a marked decrease in glucose oxidation and a corresponding increase in fatty acid catabolism. Although no overt cardiomyopathy was observed in the PDK4 transgenic mice, introduction of the PDK4 transgene into mice expressing a constitutively active form of the phosphatase calcineurin, which causes cardiac hypertrophy, caused cardiomyocyte fibrosis and a striking increase in mortality. These results demonstrate that cardiac-specific overexpression of PDK4 is sufficient to cause a loss of metabolic flexibility that exacerbates cardiomyopathy caused by the calcineurin stress-activated pathway.

Original languageEnglish
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume294
Issue number2
DOIs
StatePublished - Feb 2008

Fingerprint

Calcineurin
Cardiomyopathies
Transgenic Mice
Fatty Acids
Carbohydrate Metabolism
Cardiomegaly
Nutritional Status
Transgenes
Cardiac Myocytes
Diabetes Mellitus
Fibrosis
Cardiovascular Diseases
Heart Failure
Glucose
Mortality
pyruvate dehydrogenase kinase 4

Keywords

  • Fatty acid
  • Hypertrophy
  • Transgenic mice

ASJC Scopus subject areas

  • Physiology

Cite this

Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy. / Zhao, Guixiang; Nam, Ho Jeoung; Burgess, Shawn C.; Rosaaen-Stowe, Kimberly A.; Inagaki, Takeshi; Latif, Shuaib; Shelton, John M.; McAnally, John; Bassel-Duby, Rhonda; Harris, Robert; Richardson, James A.; Kliewer, Steven A.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 294, No. 2, 02.2008.

Research output: Contribution to journalArticle

Zhao, G, Nam, HJ, Burgess, SC, Rosaaen-Stowe, KA, Inagaki, T, Latif, S, Shelton, JM, McAnally, J, Bassel-Duby, R, Harris, R, Richardson, JA & Kliewer, SA 2008, 'Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy', American Journal of Physiology - Heart and Circulatory Physiology, vol. 294, no. 2. https://doi.org/10.1152/ajpheart.00870.2007
Zhao, Guixiang ; Nam, Ho Jeoung ; Burgess, Shawn C. ; Rosaaen-Stowe, Kimberly A. ; Inagaki, Takeshi ; Latif, Shuaib ; Shelton, John M. ; McAnally, John ; Bassel-Duby, Rhonda ; Harris, Robert ; Richardson, James A. ; Kliewer, Steven A. / Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy. In: American Journal of Physiology - Heart and Circulatory Physiology. 2008 ; Vol. 294, No. 2.
@article{48e21a3e02c841278021a33f4ab243f5,
title = "Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy",
abstract = "The heart adapts to changes in nutritional status and energy demands by adjusting its relative metabolism of carbohydrates and fatty acids. Loss of this metabolic flexibility such as occurs in diabetes mellitus is associated with cardiovascular disease and heart failure. To study the long-term consequences of impaired metabolic flexibility, we have generated mice that overexpress pyruvate dehydrogenase kinase (PDK)4 selectively in the heart. Hearts from PDK4 transgenic mice have a marked decrease in glucose oxidation and a corresponding increase in fatty acid catabolism. Although no overt cardiomyopathy was observed in the PDK4 transgenic mice, introduction of the PDK4 transgene into mice expressing a constitutively active form of the phosphatase calcineurin, which causes cardiac hypertrophy, caused cardiomyocyte fibrosis and a striking increase in mortality. These results demonstrate that cardiac-specific overexpression of PDK4 is sufficient to cause a loss of metabolic flexibility that exacerbates cardiomyopathy caused by the calcineurin stress-activated pathway.",
keywords = "Fatty acid, Hypertrophy, Transgenic mice",
author = "Guixiang Zhao and Nam, {Ho Jeoung} and Burgess, {Shawn C.} and Rosaaen-Stowe, {Kimberly A.} and Takeshi Inagaki and Shuaib Latif and Shelton, {John M.} and John McAnally and Rhonda Bassel-Duby and Robert Harris and Richardson, {James A.} and Kliewer, {Steven A.}",
year = "2008",
month = "2",
doi = "10.1152/ajpheart.00870.2007",
language = "English",
volume = "294",
journal = "American Journal of Physiology",
issn = "0193-1857",
publisher = "American Physiological Society",
number = "2",

}

TY - JOUR

T1 - Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy

AU - Zhao, Guixiang

AU - Nam, Ho Jeoung

AU - Burgess, Shawn C.

AU - Rosaaen-Stowe, Kimberly A.

AU - Inagaki, Takeshi

AU - Latif, Shuaib

AU - Shelton, John M.

AU - McAnally, John

AU - Bassel-Duby, Rhonda

AU - Harris, Robert

AU - Richardson, James A.

AU - Kliewer, Steven A.

PY - 2008/2

Y1 - 2008/2

N2 - The heart adapts to changes in nutritional status and energy demands by adjusting its relative metabolism of carbohydrates and fatty acids. Loss of this metabolic flexibility such as occurs in diabetes mellitus is associated with cardiovascular disease and heart failure. To study the long-term consequences of impaired metabolic flexibility, we have generated mice that overexpress pyruvate dehydrogenase kinase (PDK)4 selectively in the heart. Hearts from PDK4 transgenic mice have a marked decrease in glucose oxidation and a corresponding increase in fatty acid catabolism. Although no overt cardiomyopathy was observed in the PDK4 transgenic mice, introduction of the PDK4 transgene into mice expressing a constitutively active form of the phosphatase calcineurin, which causes cardiac hypertrophy, caused cardiomyocyte fibrosis and a striking increase in mortality. These results demonstrate that cardiac-specific overexpression of PDK4 is sufficient to cause a loss of metabolic flexibility that exacerbates cardiomyopathy caused by the calcineurin stress-activated pathway.

AB - The heart adapts to changes in nutritional status and energy demands by adjusting its relative metabolism of carbohydrates and fatty acids. Loss of this metabolic flexibility such as occurs in diabetes mellitus is associated with cardiovascular disease and heart failure. To study the long-term consequences of impaired metabolic flexibility, we have generated mice that overexpress pyruvate dehydrogenase kinase (PDK)4 selectively in the heart. Hearts from PDK4 transgenic mice have a marked decrease in glucose oxidation and a corresponding increase in fatty acid catabolism. Although no overt cardiomyopathy was observed in the PDK4 transgenic mice, introduction of the PDK4 transgene into mice expressing a constitutively active form of the phosphatase calcineurin, which causes cardiac hypertrophy, caused cardiomyocyte fibrosis and a striking increase in mortality. These results demonstrate that cardiac-specific overexpression of PDK4 is sufficient to cause a loss of metabolic flexibility that exacerbates cardiomyopathy caused by the calcineurin stress-activated pathway.

KW - Fatty acid

KW - Hypertrophy

KW - Transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=39149096269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39149096269&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00870.2007

DO - 10.1152/ajpheart.00870.2007

M3 - Article

C2 - 18083902

AN - SCOPUS:39149096269

VL - 294

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1857

IS - 2

ER -